Literature DB >> 2190921

[Ca2+], not diacylglycerol, is the primary regulator of sustained swine arterial smooth muscle contraction.

C M Rembold1, B A Weaver.   

Abstract

Sustained smooth muscle contraction has been proposed to be regulated by either 1) sustained increases in intracellular Ca2+ concentration [(Ca2+]i)-dependent myosin phosphorylation or 2) diacylglycerol-dependent protein kinase C activation. We measured diacylglycerol mass with the diacylglycerol kinase assay and myoplasmic [Ca2+] with aequorin in swine carotid medial smooth muscle. Sustained and significant increases in [Ca2+], myosin light chain phosphorylation, and isometric stress were observed with histamine or endothelin stimulation. Neither stimuli, however, induced significant increases in diacylglycerol mass. Relaxation of histamine-stimulated tissues was induced by removal of histamine or removal of extracellular CaCl2 in the continued presence of histamine. The rate of decline of both [Ca2+] and force was similar in both protocols, suggesting that removal of Ca2+ (without removing the stimulus) was equivalent to removal of the stimulus. These data suggest that [Ca2+]i is the primary regulator of sustained swine arterial smooth muscle contraction, whereas diacylglycerol has, at most, only a minor role.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2190921     DOI: 10.1161/01.hyp.15.6.692

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  2 in total

1.  Independent pathways regulate the cytosolic [Ca2+] initial transient and subsequent oscillations in individual cultured arterial smooth muscle cells responding to extracellular ATP.

Authors:  M G Mahoney; C J Randall; J J Linderman; D J Gross; L L Slakey
Journal:  Mol Biol Cell       Date:  1992-05       Impact factor: 4.138

2.  Phenylephrine-induced translocation of protein kinase C and shortening of two types of vascular cells of the ferret.

Authors:  R A Khalil; K G Morgan
Journal:  J Physiol       Date:  1992-09       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.